Investment Stage

Focus Areas

About Investor

Sarah Wang is a General Partner on the Growth Fund at Andreessen Horowitz in San Francisco, focusing her $10 K–$100 M growth-stage investments on Series B biotech, consumer-internet, enterprise software and fintech companies. She most recently invested in Monogram Health, a digital-care platform for heart disease. Prior to a16z, she managed growth equity at Bain Capital and drove user acquisition at fast-scaling consumer apps.